CAMP4 Therapeutics Corporation

Healthcare

NASDAQ:CAMP · NASDAQ Global Market

Market Cap $87.93M Beta 0.08 P/E (TTM) -2.8

$4.13 +2.42%

+$0.10 today

52W Low $1.31High $7.75

Vol 0.16M · Avg 0.10M

EPS (TTM) -$1.49Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+163.06%

Period High

$7.13

Period Low

$1.35

Latest

$4.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

ALX Oncology Holdings Inc.

NASDAQ:ALXO

$193.10M

Unicycive Therapeutics, Inc.

NASDAQ:UNCY

$145.60M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Repare Therapeutics Inc.

RPTX

$114.24M

MindWalk Holdings Corp.

NASDAQ:HYFT

$70.30M

Biomea Fusion, Inc.

NASDAQ:BMEA

$69.43M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$59.46M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$48.75M

aTyr Pharma, Inc.

ATYR

$45.04M

Quince Therapeutics, Inc.

QNCX

$5.02M

What is the latest CAMP filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does CAMP have?

Intrinsic Alpha currently shows 20 recent filings for CAMP.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.